BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 28711078)

  • 1. Preeclampsia: Pathogenesis, Prevention, and Long-Term Complications.
    Jim B; Karumanchi SA
    Semin Nephrol; 2017 Jul; 37(4):386-397. PubMed ID: 28711078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic Imbalance as a Contributor of Preeclampsia.
    Dymara-Konopka W; Laskowska M; Błażewicz A
    Curr Pharm Biotechnol; 2018; 19(10):797-815. PubMed ID: 30255753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic Factors in Preeclampsia: From Diagnosis to Therapy.
    Karumanchi SA
    Hypertension; 2016 Jun; 67(6):1072-9. PubMed ID: 27067718
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eclampsia in the 21st century.
    Fishel Bartal M; Sibai BM
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1237-S1253. PubMed ID: 32980358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balance of antiangiogenic and angiogenic factors in the context of the etiology of preeclampsia.
    Seki H
    Acta Obstet Gynecol Scand; 2014 Oct; 93(10):959-64. PubMed ID: 25139038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic Markers and Cardiovascular Indices in the Prediction of Hypertensive Disorders of Pregnancy.
    Verlohren S; Perschel FH; Thilaganathan B; Dröge LA; Henrich W; Busjahn A; Khalil A
    Hypertension; 2017 Jun; 69(6):1192-1197. PubMed ID: 28461601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
    Levine RJ; Lam C; Qian C; Yu KF; Maynard SE; Sachs BP; Sibai BM; Epstein FH; Romero R; Thadhani R; Karumanchi SA;
    N Engl J Med; 2006 Sep; 355(10):992-1005. PubMed ID: 16957146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
    Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of endothelial dysfunction in preeclampsia and neonatal morbidity: a case-control study.
    Masoura S; Kalogiannidis I; Makedou K; Theodoridis T; Koiou K; Gerou S; Athanasiadis A; Agorastos T
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():119-23. PubMed ID: 24485669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines.
    Phipps E; Prasanna D; Brima W; Jim B
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):1102-1113. PubMed ID: 27094609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic biomarkers in pregnancy: defining maternal and fetal health.
    Rasmussen LG; Lykke JA; Staff AC
    Acta Obstet Gynecol Scand; 2015 Aug; 94(8):820-32. PubMed ID: 25753566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental origins of angiogenic dysfunction in mirror syndrome.
    Bixel K; Silasi M; Zelop CM; Lim KH; Zsengeller Z; Stillman IE; Rana S
    Hypertens Pregnancy; 2012; 31(2):211-7. PubMed ID: 22150085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstetric nephrology: preeclampsia--the nephrologist's perspective.
    Umans JG
    Clin J Am Soc Nephrol; 2012 Dec; 7(12):2107-13. PubMed ID: 23065496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
    Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R
    J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preeclampsia: new insights.
    Shah DM
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):213-20. PubMed ID: 17420664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic factors in preeclampsia: so complex, so simple?
    Berkane N; Lefevre G; Hertig A
    Nephrol Dial Transplant; 2007 Oct; 22(10):2753-6. PubMed ID: 17617654
    [No Abstract]   [Full Text] [Related]  

  • 19. Biomarkers for Adverse Pregnancy Outcomes in Rheumatic Diseases.
    Soh MC; Nelson-Piercy C
    Rheum Dis Clin North Am; 2017 May; 43(2):201-214. PubMed ID: 28390563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictive and prognostic factors of preeclampsia: Interest of PlGF and sFLT-1].
    Vieillefosse S; Guibourdenche J; Atallah A; Haddad B; Fournier T; Tsatsaris V; Lecarpentier E
    J Gynecol Obstet Biol Reprod (Paris); 2016 Nov; 45(9):999-1008. PubMed ID: 27212611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.